AbTrace: Combating AMR with Blockchain-Enabled Transparency

The antibiotic supply chain is traceable with AbTrace's immutable blockchain ledger. The blockchain tracks antibiotic use using scannable, unique package identifiers. Pharmacies and healthcare providers can post package patterns to the blockchain using a smartphone app. The data will enable real-time antibiotic use tracking, AMR trend analysis, and risk mitigation

The team lead for our AbTrace technology solution is Dr. Abdul Wahid, who also serves as the CTO of our organisation. 

Our solution addresses the escalating problem of antimicrobial resistance (AMR), exacerbated by the indiscriminate use of antibiotics in both the human and animal sectors. Globally, the use of antibiotics in food animals is projected to surge from over 131,000 tonnes in 2013 to more than 200,000 tonnes by 2030. This issue is particularly acute in India, where antimicrobial usage (AMU) intensity in food-producing animals is significantly higher than the global average—43% more in 2020, with expectations to remain 40% higher by 2030. The misuse of antibiotics, driven partly by the lack of comprehensive and transparent data on antibiotic distribution and consumption, contributes to one of the highest rates of AMR worldwide. This situation poses a dire risk not only to animal health but also escalates the threat of drug-resistant infections in humans. Our solution, leveraging blockchain technology for traceable antibiotic tracking, aims to mitigate these risks by providing real-time data to regulate and reduce the unnecessary use of antibiotics. By doing so, we address a critical gap in current AMR mitigation strategies, focusing on one of the root causes of AMR and aiming to protect millions of lives at risk from drug-resistant infections.

The AbTrace solution caters to a broad audience with various needs for the management and control of antibiotic use. Here's who it serves and who needs it

Healthcare Providers and Veterinarians: Appropriate treatment and AMR prevention require accurate antibiotic prescription and usage data. To ensure antibiotics are authentic and utilised properly, AbTrace lets healthcare providers track their origin and dissemination.

Regulatory Bodies and Policymakers: Valid, real-time data for policymaking, regulation, and compliance. Provides a complete and transparent antibiotic supply chain view to enable AMR-reducing policies.

Pharmaceutical Manufacturers: A system to protect their brand integrity and verify that their products are used correctly. Ensures that their products are tracked and that any deviation from the intended use can be quickly identified and addressed.

Farmers and Animal Husbandry Practitioners: Sustainable antibiotic options for animal health and production. Provides info on plant-based antibiotic alternatives and optimal use to help them embrace ethical antibiotic practice

Consumers and the General Public: They should eat animal products without antibiotic usage, which might cause AMR. Ensuring animal products come from responsible antibiotic users builds food safety trust.

Global Health Community: Effective global AMR prevention measures. Provides data-driven insights to support international AMR control efforts, improving global health.

The AbTrace solution is designed to serve the public good by addressing the global challenge of antimicrobial resistance (AMR). This is achieved by creating a system that enhances the management of antibiotic distribution and usage, thereby contributing to the protection of these vital medications.

By ensuring that antibiotics are used responsibly, AbTrace helps maintain their effectiveness, directly impacting the treatment of infectious diseases and the health of the population. The technology provides valuable data that can be used to monitor and analyse antibiotic usage patterns, leading to better-informed public health strategies and interventions. By mitigating the rise of AMR, AbTrace helps to prolong the efficacy of existing antibiotics, ensuring that they remain a viable treatment option for future generations. It fosters cooperation among healthcare providers, policymakers, researchers, and the tech community, which is essential for addressing complex health issues like AMR. By curbing the spread of resistant bacteria, AbTrace supports global health security efforts, reducing the risk of untreatable infections and associated healthcare costs. The solution advocates for sustainable antibiotic use, which is crucial for the balance of ecosystems and the well-being of both human and animal populations.

AbTrace is a blockchain-based solution designed to combat antimicrobial resistance (AMR) by ensuring transparent and traceable antibiotic usage from production to consumption. This innovative approach targets stakeholders in healthcare, agriculture, and pharmaceutical industries, emphasising the need for responsible antibiotic management. By leveraging blockchain technology, AbTrace facilitates the immutable record-keeping of antibiotic transactions, supports real-time analytics, and aids in policymaking. It aims to preserve antibiotic efficacy, promote sustainable use, and ultimately safeguard public health against the burgeoning threat of AMR. This system promises a significant impact by enhancing accountability and reducing the misuse of antibiotics globally.

1. Short-term (Next Year):

   • Pilot Projects: Implement pilot projects in select regions to demonstrate efficacy and gather real-world data.
   • Stakeholder Engagement: Increase engagement with key stakeholders in the healthcare, agriculture, and pharmaceutical sectors to build partnerships.
   • Technology Optimisation: Refine the blockchain technology and mobile app based on feedback from initial users.

2. Medium-term (Next 3 Years):

   • Expansion: Gradually expand the programme to more regions, adapting strategies based on lessons learned from the pilot projects.
   • Policy Advocacy: Use data and success stories from early implementations to advocate for policy changes supporting responsible antibiotic use.
   • Collaborations: Establish collaborations with international health organisations and governments to scale the solution globally.

This approach would involve iterative development, continuous feedback integration, strategic partnerships, and advocacy to scale the impact effectively over the outlined periods.

Implementation of Pilot Projects: Conduct pilot initiatives in specific locations or sectors to assess the solution's real-world efficacy. Early pilot project success might indicate a wider impact.

1. Key Performance Indicators (KPIs): Establish specific, measurable indicators, such as:

   • Reduction in the incidence of AMR infections in targeted areas.
   • Compliance rates with antibiotic prescribing and dispensing guidelines.
   • The number of antibiotics tracked and authenticated through the system.
   • Engagement levels of stakeholders with the system (e.g., healthcare providers, pharmacists, regulators).

2. Data Analytics and Reporting: Use blockchain and mobile app data to understand antibiotic consumption, misuse, and intervention effectiveness. Machine learning systems could detect AMR hotspots and inform targeted responses.

3. Stakeholder Feedback: Regularly gather and assess feedback from healthcare practitioners, patients, regulators, and pharmaceutical companies. Continuous improvement and scaling of the solution require this feedback.

4. Policy Impact Assessment: Assess how AbTrace-enabled data-driven policies and actions affect AMR trends. This might involve working with public health researchers to compare AMR rates and antibiotic use before and after AbTrace-driven strategies.

5. Sustainability and Scale-up Metrics: Assess the economic sustainability of the solution through cost-benefit analyses and the feasibility of scaling up the solution to larger populations and different geographic regions.

Financial Barriers

• Challenge: Securing continuous funding for development, deployment, and scaling.
• Strategy: Pursue a mix of funding sources including grants, partnerships with healthcare and agricultural organizations, and investment from venture capital focused on social impact.

Technical Barriers

• Challenge: Developing a robust, scalable blockchain platform that can handle the complexity of global supply chains and integrate with existing systems.
• Strategy: Engage with technology partners for blockchain development, focus on interoperability standards, and conduct rigorous pilot testing to refine the system.

 Legal and Regulatory Barriers

• Challenge: Navigating the diverse and sometimes conflicting regulatory environments across countries.
• Strategy: Work closely with legal experts and regulatory bodies to ensure compliance and actively participate in policy dialogues to advocate for supportive regulations.

 Policy and Market Barriers

• Challenge: Influencing policy changes and achieving market penetration amidst established practices and competing interests.
• Strategy: Leverage data and success stories from pilot projects to demonstrate the value of AbTrace in addressing AMR, building a case for policy support and market adoption.

The Trinity Challenge can assist in overcoming several barriers:

Technical and Development Support: Blockchain technology for antibiotic tracking by AbTrace is intriguing but complicated. With its network of tech and health specialists, the Trinity Challenge may offer technical advice, cutting-edge research, and collaborations to strengthen AbTrace's technology.

Scaling and Implementation: Scaling AbTrace across healthcare and agriculture settings with various regulatory and operational requirements is difficult. The Trinity Challenge provides access to a global network of organisations and expertise, enabling pilot initiatives and scaling methods through partnerships and collaborations for real-world impact.

Funding and Resource Mobilization: AbTrace addresses a worldwide health issue, yet funding for research, pilot testing, and scalability is difficult. The Trinity Challenge may connect public health innovators to grants, impact investors, and philanthropies. From concept to implementation, AbTrace needs this support.

Visibility and Network Access: Any new solution needs visibility and credibility. AbTrace might reach global partners, users, and supporters from healthcare, agriculture, technology, and public policy by participating in The Trinity Challenge.

Healthcare and Pharmaceutical Companies: Pharmaceutical businesses might integrate AbTrace's blockchain technology into the drug supply chain to improve traceability from manufacturing to use. Through partnerships, healthcare professionals could adopt and use the antibiotic prescription tracking system.

Agricultural and Livestock Associations: Working with organisations in the agricultural sector, especially those involved with livestock, could help address the overuse of antibiotics in animal husbandry, a significant contributor to AMR.

Technology and Blockchain Companies: Partnering with firms that specialise in blockchain technology could provide the necessary expertise and resources to develop, refine, and scale AbTrace's technological infrastructure.

Government Health Agencies and International Health Organisations: Collaborating with organisations such as the World Health Organisation (WHO), the Food and Agriculture Organisation (FAO), and national health departments could support policy development and implementation, facilitate access to funding, and provide a platform for global adoption.

Research Institutions and Academia: Collaboration with academic institutions could support ongoing research and development, pilot studies, and the evaluation of the solution's effectiveness.